Key result
Circulating miR-24-3p expression was highest in obese children with metabolic syndrome and accurately distinguished healthy individuals from obese children (AUC = 0.951).
Why the study?
Obesity is a major risk factor for metabolic disorders in children, motivating the evaluation of circulating miR-24-3p dysregulation and its predictive value for metabolic syndrome.
Does serum miR-24-3p predict the occurrence of metabolic syndrome in children with obesity?
Observational (n=147)
Does serum miR-24-3p predict the occurrence of metabolic syndrome in children with obesity?
Circulating miR-24-3p is a potential noninvasive biomarker that correlates with metabolic parameters and predicts metabolic syndrome in obese children.
Elevated miR-24-3p may flag metabolic syndrome risk in obese children; leaves open prospective validation before clinical adoption.
INTRODUCTION: Obesity is a major risk factor for metabolic disorders in children. Therefore, it is particularly important to study the abnormal regulation of circulating miR-24-3p in obese children and its predictive value for metabolic syndrome. METHODS: Serum samples were obtained from children with obesity (n = 45), obese children with metabolic syndrome (n = 52), and healthy controls (n = 50). The expression levels of miR-24-3p were detected by reverse transcription quantitative PCR. The ROC curve was used to evaluate the diagnostic value of miR-24-3p. Pearson's correlation analysis was performed to evaluate the relationship between serum miR-24-3p and different clinical parameters. Logistic regression analysis was used to evaluate the relationship between miR-24-3p and obesity with metabolic syndrome in children. RESULTS: The expression of miR-24-3p was the highest in obese children with metabolic syndrome. ROC results showed that miR-24-3p had the ability to distinguish healthy individuals from obese children (area under the curve [AUC] = 0.951) and can predict the occurrence of metabolic syndrome for obese children (AUC = 0.890). The expression level of miR-24-3p was positively correlated with body mass index (r = 0.817, p < 0.001), fasting blood glucose (r = 0.798, p < 0.001), triglycerides (r = 0.773, p < 0.001), systolic blood pressure (r = 0.746, p < 0.001), and diastolic blood pressure (r = 0.623, p < 0.001), respectively. Logistic regression analysis showed that miR-24-3p was an independent influence factor for the occurrence of metabolic syndrome in obese children. DISCUSSION/CONCLUSION: MiR-24-3p is a potential noninvasive marker for children with obesity and has predictive value for the occurrence of metabolic syndrome.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2021) conducted an observational in Obesity and metabolic syndrome (n=147). Circulating miR-24-3p expression vs. Healthy controls was evaluated on Ability to distinguish healthy individuals from obese children and predict metabolic syndrome (AUC 0.951 for distinguishing healthy from obese; AUC 0.890 for predicting metabolic syndrome). Circulating miR-24-3p expression was highest in obese children with metabolic syndrome and accurately distinguished healthy individuals from obese children (AUC = 0.951).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: